These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31017030)
1. Modern pediatric formulations of the soft candies in the form of a jelly: determination of metoclopramide content and dissolution. Karaiskou SG; Kouskoura MG; Markopoulou CK Pharm Dev Technol; 2020 Jan; 25(1):20-27. PubMed ID: 31017030 [TBL] [Abstract][Full Text] [Related]
2. Rat Palatability Study for Taste Assessment of Caffeine Citrate Formulation Prepared via Hot-Melt Extrusion Technology. Tiwari RV; Polk AN; Patil H; Ye X; Pimparade MB; Repka MA AAPS PharmSciTech; 2017 Feb; 18(2):341-348. PubMed ID: 26573158 [TBL] [Abstract][Full Text] [Related]
3. Trends in pharmaceutical taste masking technologies: a patent review. Ayenew Z; Puri V; Kumar L; Bansal AK Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):26-39. PubMed ID: 19149727 [TBL] [Abstract][Full Text] [Related]
4. Zero-order release profile of metoclopramide hydrochloride sublingual tablet formulation. Latif R Pharm Dev Technol; 2013; 18(6):1372-8. PubMed ID: 22963706 [TBL] [Abstract][Full Text] [Related]
5. Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration. Lopalco A; Denora N; Laquintana V; Cutrignelli A; Franco M; Robota M; Hauschildt N; Mondelli F; Arduino I; Lopedota A Int J Pharm; 2020 Jan; 574():118922. PubMed ID: 31836482 [TBL] [Abstract][Full Text] [Related]
6. Advanced stable lipid-based formulations for a patient-centric product design. Becker K; Saurugger EM; Kienberger D; Lopes D; Haack D; Köberle M; Stehr M; Lochmann D; Zimmer A; Salar-Behzadi S Int J Pharm; 2016 Jan; 497(1-2):136-49. PubMed ID: 26621689 [TBL] [Abstract][Full Text] [Related]
7. Is rat a good model for assessment of particulate-based taste-masked formulations? Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218 [TBL] [Abstract][Full Text] [Related]
12. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform. Chandrasekaran P; Kandasamy R AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260 [TBL] [Abstract][Full Text] [Related]
13. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics. Thabet Y; Klingmann V; Breitkreutz J J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193 [TBL] [Abstract][Full Text] [Related]
14. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations. Giacoia GP; Taylor-Zapata P; Zajicek A Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008 [TBL] [Abstract][Full Text] [Related]
15. Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms. Arima H; Higashi T; Motoyama K Ther Deliv; 2012 May; 3(5):633-44. PubMed ID: 22834407 [TBL] [Abstract][Full Text] [Related]
16. Amoxicillin chewable tablets intended for pediatric use: formulation development, stability evaluation and taste assessment. Synaridou MS; Monou PK; Zacharis CK; Fatouros DG; Panderi I; Markopoulou CK Pharm Dev Technol; 2021 Nov; 26(9):978-988. PubMed ID: 34387136 [TBL] [Abstract][Full Text] [Related]
17. Dissolution methodology for taste masked oral dosage forms. Gittings S; Turnbull N; Roberts CJ; Gershkovich P J Control Release; 2014 Jan; 173():32-42. PubMed ID: 24184344 [TBL] [Abstract][Full Text] [Related]
18. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C; Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069 [TBL] [Abstract][Full Text] [Related]
19. Effect of different polymers and their combinations on the release of metoclopramide HCl from sustained-release hydrophilic matrix tablets. Savaşer A; Taş Ç; Bayrak Z; Özkan CK; Özkan Y Pharm Dev Technol; 2013; 18(5):1122-30. PubMed ID: 22881478 [TBL] [Abstract][Full Text] [Related]
20. The Application of 3D Printing in the Formulation of Multilayered Fast Dissolving Oral Films. Ehtezazi T; Algellay M; Islam Y; Roberts M; Dempster NM; Sarker SD J Pharm Sci; 2018 Apr; 107(4):1076-1085. PubMed ID: 29208374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]